Fibroid-associated heavy menstrual bleeding: Correlation between clinical features, doppler ultrasound assessment of vasculature, and tissue gene expression profiles

Reproductive Sciences

Volumn 20, Issue 4, 2013, Pages 361-370

  Tsiligiannis, Sophia E ^a   Zaitseva, Marina ^b   Coombs, Peter R ^a,c   Shekleton, Paul ^a,c   Olshansky, Moshe ^d   Hickey, Martha ^b   Vollenhoven, Beverley ^a,e   Rogers, Peter A W ^b  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH MEDICAL CENTRE   (Australia)

^d WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^e Women's and Children's Program   (Australia)

Author keywords

angiogenesis; Doppler ultrasound; heavy menstrual bleeding; leiomyoma

Indexed keywords

GELATINASE B; NEUROPILIN 2;

ADULT; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HEAVY MENSTRUAL BLEEDING; HUMAN; HUMAN TISSUE; HYSTERECTOMY; MENSTRUATION DISORDER; PRIORITY JOURNAL; UTERUS BLOOD FLOW; UTERUS MYOMA;

ADULT; FEMALE; HUMANS; LEIOMYOMA; MENORRHAGIA; MIDDLE AGED; TRANSCRIPTOME; ULTRASONOGRAPHY, DOPPLER, COLOR; UTERUS;

EID: 84875699657     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719112459233     Document Type: Article

References (42)

1. Day Baird D, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003 ; 188 (1). 100-107
2. Cramer SF, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol. 1990 ; 94 (4). 435-438
3. Buttram VC, Reiter RC. Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril. 1981 ; 36 (4). 433-445
4. Hartmann KE, Birnbaum H, Ben-Hamadi R, et al. Annual costs associated with diagnosis of uterine leiomyomata. Obstet Gynecol. 2006 ; 108 (4). 930-937
5. Lefebvre G, Vilos G, Allaire C, et al. The management of uterine leiomyomas. J Obstet Gynaecol Can. 2003 ; 25 (5). 396-418
6. Farrer-Brown G, Beilby JO, Rowles PM. Microvasculature of the uterus. An injection method of study. Obstet Gynecol. 1970 ; 35 (1). 21-30
7. Makhija D, Mathai AM, Naik R, et al. Morphometric evaluation of endometrial blood vessels. Indian J Pathol Microbiol. 2008 ; 51 (3). 346-350
8. Hickey M, Fraser I. Human uterine vascular structures in normal and diseased states. Microsc Res Tech. 2003 ; 60 (4). 377-389
9. Parker WH. Uterine myomas: management. Fertil Steril. 2007 ; 88 (2). 255-271
10. Faulkner RL. The blood vessels of the myomatous uterus. Am J Obstet Gynaecol. 1944 ; 47: 185-197
11. Weston G, Trajstman AC, Gargett CE, Manuelpillai U, Vollenhoven BJ, Rogers PA. Fibroids display an anti-angiogenic gene expression profile when compared with adjacent myometrium. Mol Hum Reprod. 2003 ; 9 (9). 541-549
12. Sampson J. The influence of myomata on the blood supply of the uterus, with special reference to abnormal uterine bleeding. Surg Gynecol Obstet. 1912 ; 16: 144-180
13. Tsibris JC, Segars J, Coppola D, et al. Insights from gene arrays on the development and growth regulation of uterine leiomyomata. Fertil Steril. 2002 ; 78 (1). 114-121
14. Ahn WS, Kim KW, Bae SM, et al. Targeted cellular process profiling approach for uterine leiomyoma using cDNA microarray, proteomics and gene ontology analysis. Int J Exp Pathol. 2003 ; 84 (6). 267-279
15. Quade BJ, Wang TY, Sornberger K, Dal Cin P, Mutter GL, Morton CC. Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling. Genes Chromosomes Cancer. 2004 ; 40 (2). 97-108
16. Arslan AA, Gold LI, Mittal K, et al. Gene expression studies provide clues to the pathogenesis of uterine leiomyoma: new evidence and a systematic review. Hum Reprod. 2005 ; 20 (4). 852-863
17. Lee EJ, Kong G, Lee SH, et al. Profiling of differentially expressed genes in human uterine leiomyomas. Int J Gynecol Cancer. 2005 ; 15 (1). 146-154
18. Vanharanta S, Wortham NC. Laiho P, et al. 7q deletion mapping and expression profiling in uterine fibroids. Oncogene. 2005 ; 24 (43). 6545-6554
19. Zaitseva M, Vollenhoven BJ, Rogers PA.. In vitro culture significantly alters gene expression profiles and reduces differences between myometrial and fibroid smooth muscle cells. Mol Hum Reprod. 2006 ; 12 (3). 187-207
20. Zaitseva M, Vollenhoven BJ, Rogers PA. Retinoids regulate genes involved in retinoic acid synthesis and transport in human myometrial and fibroid smooth muscle cells. Hum Reprod. 2008 ; 23 (5). 1076-1086
21. Bodner-Adler B, Nather A, Bodner K, et al. Expression of thrombospondin 1 (TSP 1) in patients with uterine smooth muscle tumors: an immunohistochemical study. Gynecol Oncol. 2006 ; 103 (1). 186-189
22. Behera MA, Feng L, Yonish B, Catherino W, Jung SH, Leppert P. Thrombospondin-1 and thrombospondin-2 mRNA and TSP-1 and TSP-2 protein expression in uterine fibroids and correlation to the genes COL1A1 and COL3A1 and to the collagen cross-link hydroxyproline. Reprod Sci. 2007 ; 14 (8 suppl). 63-76
23. Iwahashi M, Muragaki Y. Increased type I and V collagen expression in uterine leiomyomas during the menstrual cycle. Fertil Steril. 2011 ; 95 (6). 2137-2139
24. Leppert PC, Catherino WH, Segars JH. A new hypothesis about the origin of uterine fibroids based on gene expression profiling with microarrays. Am J Obstet Gynecol. 2006 ; 195 (2). 415-420
25. Chegini N. Proinflammatory and profibrotic mediators: principal effectors of leiomyoma development as a fibrotic disorder. Semin Reprod Med. 2010 ; 28 (3). 180-203
26. Wolanska M, Sobolewski K, Bankowski E, Jaworski S. Matrix metalloproteinases of human leiomyoma in various stages of tumor growth. Gynecol Obstet Invest. 2004 ; 58 (1). 14-18
27. Bogusiewicz M, Stryjecka-Zimmer M, Postawski K, Jakimiuk AJ, Rechberger T. Activity of matrix metalloproteinase-2 and -9 and contents of their tissue inhibitors in uterine leiomyoma and corresponding myometrium. Gynecol Endocrinol. 2007 ; 23 (9). 541-546
28. Jiang Y, Suo G, Sadarangani A, Cowan B, Wang JY. Expression profiling of protein tyrosine kinases and their ligand activators in leiomyoma uteri. Syst Biol Reprod Med. 2010 ; 56 (4). 318-326
29. Casey R, Rogers PA, Vollenhoven BJ. An immunohistochemical analysis of fibroid vasculature. Hum Reprod. 2000 ; 15 (7). 1469-1475
30. Brauer MM. Cellular and molecular mechanisms underlying plasticity in uterine sympathetic nerves. Auton Neurosci. 2008 ; 140 (1-2). 1-16
31. Augustin HG, Koh GY, Thurston G, Alitalo K. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol. 2009 ; 10 (3). 165-177
32. Bagri A, Tessier-Lavigne M, Watts RJ. Neuropilins in tumor biology. Clin Cancer Res. 2009 ; 15 (6). 1860-1864
33. Bhuvaneswari R, Gan YY, Lucky SS, et al. Molecular profiling of angiogenesis in hypericin mediated photodynamic therapy. Mol Cancer. 2008 ; 7: 56
34. Shimomura Y, Matsuo H, Samoto T, Maruo T. Up-regulation by progesterone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma. J Clin Endocrinol Metab. 1998 ; 83 (6). 2192-2198
35. Wang J, Ohara N, Wang Z, et al. A novel selective progesterone receptor modulator asoprisnil (J867) down-regulates the expression of EGF, IGF-I, TGFbeta3 and their receptors in cultured uterine leiomyoma cells. Hum Reprod. 2006 ; 21 (7). 1869-1877
36. Wolanska M, Bankowski E. Fibroblast growth factors (FGF) in human myometrium and uterine leiomyomas in various stages of tumour growth. Biochimie. 2006 ; 88 (2). 141-146
37. Liang M, Wang H, Zhang Y, Lu S, Wang Z. Expression and functional analysis of platelet-derived growth factor in uterine leiomyomata. Cancer Biol Ther. 2006 ; 5 (1). 28-33
38. Tsai FC, Liu WM, Pai MH, Hsieh MS, Lin JY, Chou CM. Downregulation of the integrin alpha(v) signaling pathway in uterine leiomyomas. Gynecol Obstet Invest. 2011 ; 71 (2). 129-135
39. Huyen DV, Bany BM. Evidence for a conserved function of heart and neural crest derivatives expressed transcript 2 in mouse and human decidualization. Reproduction. 2011 ; 142 (2). 353-368
40. Yamamoto Y, Olson DM, van Bennekom M, Brindley DN, Hemmings DG. Increased expression of enzymes for sphingosine 1-phosphate turnover and signaling in human decidua during late pregnancy. Biol Reprod. 2010 ; 82 (3). 628-635
41. Chen L, Fan R, Huang X, Xu H, Zhang X. Decreased concentrations of pigment epithelium-derived factor in peritoneal fluid of patients with endometriosis. Fertil Steril. 2011 ; 95 (5). 1798-1800
42. Dueholm M, Lundorf E, Sorensen JS, Ledertoug S, Olesen F, Laursen H. Reproducibility of evaluation of the uterus by transvaginal sonography, hysterosonographic examination, hysteroscopy and magnetic resonance imaging. Hum Reprod. 2002 ; 17 (1). 195-200